martes, 28 de julio de 2020

Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox | BMC Cancer | Full Text

Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox | BMC Cancer | Full Text

Iron is required for cellular metabolism, and rapidly proliferating cancer cells require more of this essential nutrient. Therefore, iron regulation may well represent a new avenue for cancer therapy. We have ...
Authors:Shogo Amano, Seiji Kaino, Shuhei Shinoda, Hirofumi Harima, Toshihiko Matsumoto, Koichi Fujisawa, Taro Takami, Naoki Yamamoto, Takahiro Yamasaki and Isao Sakaida
Citation:BMC Cancer 2020 20:681
Content type:Research article
 
Published on: 

No hay comentarios:

Publicar un comentario